This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Treatment of Patients With Metastatic or Unresecta...
Clinical trial

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib (OPEN)

Read time: 1 mins
Last updated:19th Sep 2008
The purpose of this multicenter, single-arm, exact binomial single-stage, phase II trial is to evaluate the efficacy of Nilotinib in patients with unresectable or metastatic gastrointestinal stromal tumors.
Category Value
Study start date 2008-09-19

View full details